Antiviral Product Development--Conducting and Submitting Virology Studies to the Agency
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
June 5, 2006
April 24, 2020
81122360-623f-492b-84a2-d1ef7e31728f
Related Documents
Role of HIV Drug Resistance Testing in Antiretroviral Drug Development
Guidance DocumentOctober 31, 2007Center for Drug Evaluation and Research
Nonclinical Safety Evaluation of Pediatric Drug Products
Guidance DocumentFebruary 15, 2006Center for Drug Evaluation and Research
Internal Radioactive Contamination —Development of Decorporation Agents
Guidance DocumentMarch 2, 2006Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.